Litcius/Paper detail

Comparison of Glucagon-Like Peptide-1 Receptor Agonists and Sodium-Glucose Cotransporter Protein-2 Inhibitors on Treating Metabolic Dysfunction-Associated Steatotic Liver Disease or Metabolic Dysfunction-Associated Steatohepatitis: Systematic Review and Network Meta-Analysis of Randomised Controlled Trials

Ruhan Xu, Bo Liu, Xianghai Zhou

2024Endocrine Practice12 citationsDOI

Topics & Concepts

MedicineSteatohepatitisGlucagon-like peptide-1Fatty liverInternal medicineDiseaseEndocrinologyMetabolic diseaseDiabetes mellitusType 2 diabetesLiver Disease Diagnosis and TreatmentDiabetes Treatment and ManagementLiver Disease and Transplantation
Comparison of Glucagon-Like Peptide-1 Receptor Agonists and Sodium-Glucose Cotransporter Protein-2 Inhibitors on Treating Metabolic Dysfunction-Associated Steatotic Liver Disease or Metabolic Dysfunction-Associated Steatohepatitis: Systematic Review and Network Meta-Analysis of Randomised Controlled Trials | Litcius